{
    "clinical_study": {
        "@rank": "23606", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Determine the effects of aminoimidazole carboxamide riboside (AICAR) on\n      hematologic manifestations of Lesch-Nyhan disease.\n\n      II.  Assess the behavioral and neurological benefits of AICAR in patients with Lesch-Nyhan\n      disease.\n\n      III.  Examine the effect of AICAR on purine production."
        }, 
        "brief_title": "Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease", 
        "condition": "Lesch-Nyhan Syndrome", 
        "condition_browse": {
            "mesh_term": "Lesch-Nyhan Syndrome"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      After a 3-day baseline, patients are treated with aminoimidazole carboxamide riboside\n      (AICAR) by continuous infusion for 12 days.  Concurrent allopurinol and folate are allowed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Men with Lesch-Nyhan syndrome Moderate erythrocyte\n        macrocytosis No active urinary tract disease or impaired renal function"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "2", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004314", 
            "org_study_id": "199/11823", 
            "secondary_id": "UCSD-733"
        }, 
        "intervention": {
            "intervention_name": "aminomidazole carboxamide riboside", 
            "intervention_type": "Drug"
        }, 
        "keyword": [
            "Lesch-Nyhan syndrome", 
            "inborn errors of metabolism", 
            "neurologic and psychiatric disorders", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "University of California, San Diego", 
            "last_name": "Bruce Barshop", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "reference": [
            {
                "citation": "Page T, Barshop BA, Yu A, et al.: Treatment of Lesch-Nyhan syndrome with AICAR. In: Sahota A, Tayor M, eds.: Purine and Pyrimidine Metabolism in Man VIII. Plenum Press, New York, NY: 1995, pp 353-356."
            }, 
            {
                "PMID": "7660927", 
                "citation": "Page T, Barshop B, Yu AL, Nyhan WL. Treatment of Lesch-Nyhan syndrome with AICAR. Adv Exp Med Biol. 1994;370:353-6. No abstract available."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004314"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of California, San Diego", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "February 1996", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2000"
    }, 
    "geocoordinates": {}
}